astrocytosis and spongiform degeneration of appropriate distribution. Probable cases are similar but without histology. In possible cases the typical EEG is not required. These criteria can usually be successfully applied but certain exceptions will be mentioned below.
Hospital notes were sought for all cases notified as dying of Creutzfeldt-Jakob disease and in the great majority were highly informative. However, in 20 of 175 notified cases no details could be obtained, although from enquiry at local hospitals it is unlikely that Creutzfeldt-Jakob disease was the correct diagnosis in these patients. Seventynine notified cases were classed as definite, 26 as probable and eight as possible. Forty-two were judged not to have had Creutzfeldt-Jakob disease; Alzheimer's disease, with or without myoclonus, proving the most difficult distinction (table 1) . Twenty-three further definite cases, not notified as Creutzfeldt-Jakob disease, were obtained from the list already held. Nineteen definite, five probable and two possible cases were found by diligent enquiry at neurological centres. The totals ascertained for the decade are shown in table 2.
Results
Although there was naturally some overlap of clinical features, three presentations of CreutzfeldtJakob disease could be distinguished. Of these, by far the most common was the subacute form, rapidly leading to a helpless condition and early death. In the intermediate form the terminal stages Were identical but were preceded by a prolonged period of focal or diffuse neurological signs, readily leading to diagnostic confusion. In the amyotrophic form progressive dementia was accompanied or followed by extensive neurogenic muscle atrophy. This form was difficult to classify according to the diagnostic criteria. Such cases with histological confirmation of Creutzfeldt-Jakob disease were regarded as definite and those without were classified as possible. Will, Matthews often typical and characteristic changes were not seen in the amyotrophic form. The adoption of the EEG as one of the diagnostic criteria therefore presents difficulties in these uncommon forms of the disease.
Discussion
The typical clinical course in the subacute form of Creutzfeldt-Jakob disease is one of progressive dementia leading after a period of a few weeks to a decorticate state which may persist for many months before death. The clinical features described in this group accorded with previous series7'-0 and minor differences could be attributed to differing entry criteria and improving diagnostic accuracy.
In The specificity of spongiform change, as opposed to status spongiosus, as a characteristic of Creutzfeldt-Jakob disease has been stressed by Masters, '4 but this view has been recently challenged,'5 accentuating the importance of transmission to confirm the presence of the agent. The long duration of illness in amyotrophic patients may reflect a virus strain of low virulence or a low infectious dose, resulting in extended incubation and apparently failed transmission, as with species to species transmission in the laboratory. '6 There is, however, no firm evidence that amyotrophic Creutzfeldt-Jakob disease is a slow virus disease although it is of interest that the subacute form and amyotrophic form should occur in siblings of a family with apparently inherited Creutzfeldt-Jakob disease.
The overall familial incidence of 6% in this series contrasts with the estimated familial incidence of 15% in a review of the worldwide epidemiology of Creutzfeldt-Jakob disease.5 In individual series higher figures are quoted with, for example, a familial incidence of 47% in Chile'7 and 35% in Libyan born Israelis.'8 In a comprehensive survey of Creutzfeldt-Jakob disease in France,'9 however, a 9% familial incidence was discovered, a figure comparable with this series. The low familial incidence may reflect either the difficulties of retrospectively obtaining an accurate family history or an artificially high familial incidence in relatively selected series due to extensive investigation of individual families.
A further point of contrast from previous reports is the preponderance of female patients. In past series the sex incidence has been equal and the female bias in this series is unexplained. However, this finding has been continued in the prospective survey of Creutzfeldt-Jakob disease at present being carried out in England and Wales.
The routine investigation of patients with Creutzfeldt-Jakob disease has been unrewarding. The only biochemical abnormality observed in this series was minor elevation of liver enzymes or bilirubin in a minority of patients. The CT scan was usually normal in subacute cases and cortical or cerebral atrophy occurred only late in the course of the illness when the diagnosis was usually clear. Neuroradiological investigations in the subacute illness were thus helpful only in the exclusion of other conditions. In the intermediate and amyotrophic forms the CT scan was more likely to show atrophy but this was nonspecific. As the EEG is also unhelpful in the majority of these patients, the diagnosis of Creutzfeldt-Jakob disease rests on the pathological findings. The CSF was normal in the great majority of patients but a minor elevation of CSF protein may occur and in one confirmed case a level of 2 g/l was recorded. Galvez et aP20 have described a significantly higher mean total CSF protein content in cases of Creutzfeldt-Jakob disease in relation to a control group. The concentration of IgG was also found to be increased as with three patients in this series.
The accurate diagnosis of subacute cases of Creutzfeldt-Jakob disease presents little difficulty but both intermediate and amyotrophic cases share clinical features with other more common conditions and may be impossible to diagnose in life. Pathological confirmation of the diagnosis is vital for an increased understanding of the epidemiology of Creutzfeldt-Jakob disease and the, at present enigmatic, mechanism of transmission of the agent.
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